Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Avinger Inc. logo — Avinger is dedicated to radically changing the way vascular...

Avinger Inc.

Avinger is dedicated to radically changing the way vascular disease is treated.

Founded 2007 United States Redwood City, United States 73 employees Post-IPO Equity Total: $313.60M Health Care, Manufacturing +1

General Information

Company Name Avinger Inc.
Founded Year 2007
Location United States Redwood City, United States
Founders / Decision Makers
Team member
Employees 73
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Avinger Inc.. To contact Avinger Inc., visit avinger.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Avinger Inc. compare?

A PDF of Avinger Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Avinger Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Avinger Inc.

Avinger Inc. is a commercial-stage medical device company founded in 2007 in the United States. The company is dedicated to radically changing the way vascular disease is treated. Avinger designs, manufactures, and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD), characterized by a build-up of plaque in the arteries supplying blood to the arms and legs. Avinger's mission is to introduce products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. The current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters designed to penetrate total arterial blockages known as chronic total occlusions (CTOs), and Pantheris, the first-ever image-guided atherectomy device designed to precisely remove arterial plaque in PAD patients. The company received its last investment of $6.00M through a Post-IPO Equity investment on 14 June 2024. Avinger's innovative products and dedication to addressing the unmet needs in vascular disease treatment have the potential to attract further attention and support from venture capitalists and investors in the healthcare and manufacturing industries.

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $6.00M -
14 Jun 2024
Post IPO Equity $11.00M -
16 May 2024
Post IPO Equity $7.50M 1
Zylox
Zylox
06 Mar 2024
Post IPO Equity $7.60M -
12 Jan 2022
Post IPO Equity Undisclosed -
28 Jan 2021
Post IPO Equity $11.50M -
07 Nov 2018
Post IPO Equity $18.00M -
14 Feb 2018
Post IPO Equity $31.70M -
11 Aug 2016
Post IPO Equity $50.00M -
01 Feb 2016
Post IPO Equity $55.00M 1
CRG
CRG
01 Sep 2015

View All 15 Funding Rounds

Avinger Inc. Alternatives & Competitors

Avinger Inc. vs
Ra Medical Systems
Ra Medical Systems United States

Our Mission: Save lives, limbs and improve patients’ quality of life.

Post-IPO Equity
36 employees
Health Care, Medical Devices
Avinger Inc. vs
R3 Vascular Inc.
R3 Vascular Inc. United States

The Next Generation of BTK Interventional Therapies for PAD

Series B
18 employees
Health Care, Manufacturing
Compare Avinger Inc. vs R3 Vascular Inc.

FAQ About Avinger Inc.

Avinger is dedicated to radically changing the way vascular disease is treated.
Avinger Inc. was founded in 2007.
Avinger Inc. is headquartered in Redwood City, United States.
Avinger Inc. operates in Health Care, Manufacturing and Medical Devices.
Avinger Inc. has approximately 73 employees.
Avinger Inc. has completed 15 funding rounds, raising a total of $313.60M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Avinger Inc. include Ra Medical Systems, R3 Vascular Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avinger Inc. and Ra Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avinger Inc., https://bouncewatch.com/company/avinger-inc, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes